Covered recipient · General Payments record
SHAWN K LEE
Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease
General Payments · PY2018–2024
$2,271.14
- Reported across 154 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $223.20 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $93.83 | 3 |
| INOGEN, INC. | $52.73 | 4 |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.45 | 1 |
| ANI Pharmaceuticals, Inc. | $21.72 | 1 |
| Acerta Pharma LLC | $15.85 | 1 |
| Axsome Therapeutics, Inc. | $15.62 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.42 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104156224 | CMS |
| ABBVIE INC. | $32.20 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104156226 | CMS |
| ABBVIE INC. | $33.21 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104156228 | CMS |
| ANI Pharmaceuticals, Inc. | $21.72 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091137962 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.85 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104638977 | CMS |
| Axsome Therapeutics, Inc. | $15.62 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148321066 | CMS |
| INOGEN, INC. | $8.04 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144988519 | CMS |
| INOGEN, INC. | $15.89 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144988521 | CMS |
| INOGEN, INC. | $14.40 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144988523 | CMS |
| INOGEN, INC. | $14.40 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144988525 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.45 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137616725 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.